Intrinsic Value of S&P & Nasdaq Contact Us

Agios Pharmaceuticals, Inc. AGIO NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
58/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$41.50
+24.6%

Stock Statistics — AGIO

Agios Pharmaceuticals, Inc. (AGIO) has a market capitalization of $1.95B and trades at $33.30. The 52-week range is 22.24-46.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -4.7, Earnings Per Share (EPS) of $-7.12, annual revenue of $54.03M.

The stock has a beta of 0.79, operates in the Healthcare sector.

Trading Data
Current Price$33.30
52-Week Range22.24-46
Volume642.33K
Avg Volume (30D)932.7K
Market Cap$1.95B
Beta (1Y)0.79
Company
IPO Date2013-07-24
Employees486
CEOBrian Goff
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS00847X1046
CUSIP00847X104
Income (Latest Year)
Revenue$54.03M
Gross Profit$47.68M
EBITDA$-466.96M
Operating Income$-472.13M
Net Income$-412.78M
EPS$-7.12
EPS Diluted$-7.12
Shares Outstanding$57.97M
Balance Sheet (Latest Year)
Total Assets$1.3B
Current Assets$942.05M
Cash & ST Investments$854.43M
Total Liabilities$104.11M
Total Debt$62.02M
Net Debt$-27.11M
Total Equity$1.19B
Debt / Equity0.05
Valuation Ratios
P/E Ratio-4.7
P/S Ratio36.11
P/B Ratio1.64
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message